[1]
|
Kahnert, K., Jörres, R.A., Behr, J. and Welte, T. (2023) The Diagnosis and Treatment of COPD and Its Comorbidities. Deutsches Ärzteblatt International, 120, 434-444. https://doi.org/10.3238/arztebl.m2023.0027
|
[2]
|
Soriano, J.B., Polverino, F. and Cosio, B.G. (2018) What Is Early COPD and Why Is It Important? European Respiratory Journal, 52, Article 1801448. https://doi.org/10.1183/13993003.01448-2018
|
[3]
|
Aldonyte, R., Bagdonas, E., Raudoniute, J. and Bruzauskaite, I. (2015) Novel Aspects of Pathogenesis and Regeneration Mechanisms in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 10, 995-1013. https://doi.org/10.2147/copd.s82518
|
[4]
|
Vila, M., Faner, R. and Agustí, A. (2022) Beyond the COPD-Tobacco Binomium: New Opportunities for the Prevention and Early Treatment of the Disease. Medicina Clínica (English Edition), 159, 33-39. https://doi.org/10.1016/j.medcle.2022.01.011
|
[5]
|
Yang, I.A., Jenkins, C.R. and Salvi, S.S. (2022) Chronic Obstructive Pulmonary Disease in Never-Smokers: Risk Factors, Pathogenesis, and Implications for Prevention and Treatment. The Lancet Respiratory Medicine, 10, 497-511. https://doi.org/10.1016/s2213-2600(21)00506-3
|
[6]
|
Smith, M. and Wrobel, J. (2014) Epidemiology and Clinical Impact of Major Comorbidities in Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease, 9, 871-888. https://doi.org/10.2147/copd.s49621
|
[7]
|
Battaglia, A.M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F. and Biamonte, F. (2020) Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death. Cells, 9, Article 1505. https://doi.org/10.3390/cells9061505
|
[8]
|
Tong, J., Lan, X., Zhang, Z., Liu, Y., Sun, D., Wang, X., et al. (2022) Ferroptosis Inhibitor Liproxstatin-1 Alleviates Metabolic Dysfunction-Associated Fatty Liver Disease in Mice: Potential Involvement of Panoptosis. Acta Pharmacologica Sinica, 44, 1014-1028. https://doi.org/10.1038/s41401-022-01010-5
|
[9]
|
Dang, X., Huan, X., Du, X., Chen, X., Bi, M., Yan, C., et al. (2022) Correlation of Ferroptosis and Other Types of Cell Death in Neurodegenerative Diseases. Neuroscience Bulletin, 38, 938-952. https://doi.org/10.1007/s12264-022-00861-6
|
[10]
|
Tang, B., Yan, R., Zhu, J., Cheng, S., Kong, C., Chen, W., et al. (2022) Integrative Analysis of the Molecular Mechanisms, Immunological Features and Immunotherapy Response of Ferroptosis Regulators across 33 Cancer Types. International Journal of Biological Sciences, 18, 180-198. https://doi.org/10.7150/ijbs.64654
|
[11]
|
Gryzik, M., Asperti, M., Denardo, A., Arosio, P. and Poli, M. (2021) NCOA4-Mediated Ferritinophagy Promotes Ferroptosis Induced by Erastin, but Not by RSL3 in Hela Cells. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1868, Article 118913. https://doi.org/10.1016/j.bbamcr.2020.118913
|
[12]
|
Li, S. and Huang, Y. (2021) Ferroptosis: An Iron-Dependent Cell Death Form Linking Metabolism, Diseases, Immune Cell and Targeted Therapy. Clinical and Translational Oncology, 24, 1-12. https://doi.org/10.1007/s12094-021-02669-8
|
[13]
|
Zhang, Q., Fan, X., Zhang, X. and Ju, S. (2023) Ferroptosis in Tumors and Its Relationship to Other Programmed Cell Death: Role of Non-Coding RNAs. Journal of Translational Medicine, 21, Article No. 514. https://doi.org/10.1186/s12967-023-04370-6
|
[14]
|
Lin, X., Ouyang, S., Zhi, C., Li, P., Tan, X., Ma, W., et al. (2022) Focus on Ferroptosis, Pyroptosis, Apoptosis and Autophagy of Vascular Endothelial Cells to the Strategic Targets for the Treatment of Atherosclerosis. Archives of Biochemistry and Biophysics, 715, Article 109098. https://doi.org/10.1016/j.abb.2021.109098
|
[15]
|
Zhang, S., Kang, L., Dai, X., Chen, J., Chen, Z., Wang, M., et al. (2022) Manganese Induces Tumor Cell Ferroptosis through Type-I IFN Dependent Inhibition of Mitochondrial Dihydroorotate Dehydrogenase. Free Radical Biology and Medicine, 193, 202-212. https://doi.org/10.1016/j.freeradbiomed.2022.10.004
|
[16]
|
Jin, L., Yu, B., Wang, H., Shi, L., Yang, J., Wu, L., et al. (2023) STING Promotes Ferroptosis through NCOA4-Dependent Ferritinophagy in Acute Kidney Injury. Free Radical Biology and Medicine, 208, 348-360. https://doi.org/10.1016/j.freeradbiomed.2023.08.025
|
[17]
|
Distéfano, A.M., López, G.A., Setzes, N., Marchetti, F., Cainzos, M., Cascallares, M., et al. (2020) Ferroptosis in Plants: Triggers, Proposed Mechanisms, and the Role of Iron in Modulating Cell Death. Journal of Experimental Botany, 72, 2125-2135. https://doi.org/10.1093/jxb/eraa425
|
[18]
|
Li, J., Yao, Y. and Tian, Y. (2021) Ferroptosis: A Trigger of Proinflammatory State Progression to Immunogenicity in Necroinflammatory Disease. Frontiers in Immunology, 12, Article 701163. https://doi.org/10.3389/fimmu.2021.701163
|
[19]
|
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., et al. (2022) Targeting Cell Death Pathways for Cancer Therapy: Recent Developments in Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis Research. Journal of Hematology & Oncology, 15, Article No. 174. https://doi.org/10.1186/s13045-022-01392-3
|
[20]
|
Xu, Y., Li, Y., Li, J. and Chen, W. (2022) Ethyl Carbamate Triggers Ferroptosis in Liver through Inhibiting GSH Synthesis and Suppressing Nrf2 Activation. Redox Biology, 53, Article 102349. https://doi.org/10.1016/j.redox.2022.102349
|
[21]
|
Lee, J. and Roh, J. (2023) Epigenetic Modulation of Ferroptosis in Cancer: Identifying Epigenetic Targets for Novel Anticancer Therapy. Cellular Oncology, 46, 1605-1623. https://doi.org/10.1007/s13402-023-00840-7
|
[22]
|
Li, C., Chen, F., Lin, L., Li, J., Zheng, Y. and Chen, Q. (2023) CSE Triggers Ferroptosis via SIRT4-Mediated GNPAT Deacetylation in the Pathogenesis of COPD. Respiratory Research, 24, Article No. 301. https://doi.org/10.1186/s12931-023-02613-0
|
[23]
|
Zhang, Z., Fu, C., Liu, J., Sai, X., Qin, C., Di, T., et al. (2021) Hypermethylation of the Nrf2 Promoter Induces Ferroptosis by Inhibiting the Nrf2-GPX4 Axis in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 16, 3347-3362. https://doi.org/10.2147/copd.s340113
|
[24]
|
Yuan, S., Xi, S., Weng, H., Guo, M., Zhang, J., Yu, Z., et al. (2023) YTHDC1 as a Tumor Progression Suppressor through Modulating FSP1-Dependent Ferroptosis Suppression in Lung Cancer. Cell Death & Differentiation, 30, 2477-2490. https://doi.org/10.1038/s41418-023-01234-w
|